Enkilifebiotech · Newsroom
EnkiLife Launches 20 µl Trial-Size Antibody — Test Before You Invest
EnkiLife Biotech today announced its 20 µl Trial-Size Antibody Promotion, offering researchers cost-effective access to a catalog of over 16,000 targets without the financial commitment of a full-sized vial.September 17, 2026